Kovatcheva, Marta <br/><br/>
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition.  [electronic resource] 

 -  Oncotarget  Apr 2015 
 - 8226-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.3364  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cellular Senescence<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>DNA Helicases--biosynthesis<br/>Gene Knockdown Techniques<br/>Humans<br/>Liposarcoma<br/>Nuclear Proteins--biosynthesis<br/>Phosphorylation<br/>Piperazines--pharmacology<br/>Proto-Oncogene Proteins c-mdm2--metabolism<br/>Pyridines--pharmacology<br/>Retinoblastoma Protein--metabolism<br/>X-linked Nuclear Protein